🇺🇸 ranibizumab, aflibercept, pegaptanib, verteporphin in United States

ranibizumab, aflibercept, pegaptanib, verteporphin (ranibizumab, aflibercept, pegaptanib, verteporphin) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

ranibizumab, aflibercept, pegaptanib, verteporphin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is ranibizumab, aflibercept, pegaptanib, verteporphin approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for ranibizumab, aflibercept, pegaptanib, verteporphin in United States?

Kagawa University is the originator. The local marketing authorisation holder may differ — check the official source linked above.